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Kathrin Kuehni-Boghenbor2 and Paola Pilo1*Abstract
Mycoplasma bovis is a wall-less bacterium causing bovine mycoplasmosis, a disease showing a broad range of
clinical manifestations in cattle. It leads to enormous economic losses to the beef and dairy industries. Antibiotic
treatments are not efficacious and currently no efficient vaccine is available. Moreover, mechanisms of pathogenicity
of this bacterium are not clear, as few virulence attributes are known. Microscopic observations of necropsy material
suggest the possibility of an intracellular stage of M. bovis. We used a combination of a gentamicin protection assay,
a variety of chemical treatments to block mycoplasmas entry in eukaryotic cells, and fluorescence and transmission
electron microscopy to investigate the intracellular life of M. bovis in calf turbinate cells. Our findings indicate that
M. bovis invades and persists in primary embryonic calf turbinate cells. Moreover, M. bovis can multiply within these
cells. The intracellular phase of M. bovis may represent a protective niche for this pathogen and contribute to its
escape from the host’s immune defense as well as avoidance of antimicrobial agents.Introduction
The wall-less bacterium Mycoplasma bovis is the causative
agent of bovine mycoplasmosis, which is responsible for
tremendous economic losses in both beef and dairy indus-
tries [1]. The clinical spectrum of this disease is broad as
it manifests as pneumonia, mastitis, polyarthritis, otitis
media and genital disorders [2-5]. Moreover, management
of bovine mycoplasmosis is challenging as current vac-
cines are mostly ineffective [6] and antibiotic treatments
generally fail. Furthermore, emergence of M. bovis strains
resistant to antibiotics, under axenic growth conditions,
has been reported [7,8].
Virulence determinants involved in the mechanisms of
pathogenicity of M. bovis are virtually unknown. Variable
surface proteins [9] and the capacity of this bacterium to
form biofilms were identified as mechanisms contribut-
ing to the persistence of M. bovis in its natural environ-
ment [10].
Mycoplasma spp. are mainly described as extracellular
bacteria closely associated with host cells [11,12]. Be-
yond the well-studied M. penetrans [12,13], the ability of
several Mycoplasma spp. to invade non-phagocytic cells* Correspondence: paola.pilo@vetsuisse.unibe.ch
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unless otherwise stated.under specific experimental conditions was described
[14-20]. Although the role in pathogenicity of the intra-
cellular stage of these bacteria is not yet clear, it deserves
to be investigated in more detail to elucidate the mo-
lecular mechanisms involved.
The close extracellular association of M. bovis with host
cells and adhesion characteristics have been described
with occasional intracellular localizations in inflammatory
cells [21-30]. Studying lung tissues of experimentally in-
fected calves by transmission electron microscopy (TEM),
Kleinschmidt et al. recently observed M. bovis throughout
caseonecrotic foci, in the cytoplasm of degenerating mac-
rophages and the lumina of bronchi but not in the cyto-
plasm of bronchial epithelial cells [22]. Additionally, van
der Merwe et al. observed intracellular M. bovis in bovine
peripheral blood mononuclear cell populations (PBMC)
and red blood cells (RBC) following in vitro infections
[31]. Moreover, M. bovis antigens were detected inside in-
flammatory cells, hepatocytes, renal tubular epithelial cells
and facial nerve bundles of necropsy tissue samples by
immunohistochemistry and by TEM [32]. Consequently,
the intracellular stage of M. bovis in non-phagocytic cells
needs further investigations to strengthen these observa-
tions from naturally and experimentally infected animals
and cells.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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non-phagocytic host cells may contribute to the patho-
genesis of the bacterium serving as a protection niche
evading the host immune response and antibiotic treat-
ment but could also lead to systemic spread within host
blood cells. A definitive proof of the ability of M. bovis
to invade non-phagocytic cells has not been experimen-
tally demonstrated and the development of an in vitro
model is essential to dissect the molecular and cellular
mechanisms involved in the intracellular survival of M.
bovis in these cells.
The aim of the present study was to investigate inva-
sion and persistence of M. bovis in bovine non-
phagocytic cells using an in vitro model. Several comple-
mentary approaches including the gentamicin protection
assay, considered as the gold standard method for inves-
tigating bacterial invasion, chemical blocking of endocy-
tic pathways, fluorescence microscopy, as well as TEM
were performed. The results reveal that M. bovis is able
to invade and persist in bovine turbinate cells. Moreover,
M. bovis is able to replicate within these cells.
Materials and methods
Bacterial strains, primary calf turbinate cells and growth
conditions
Strains of M. bovis (Table 1) were grown at 37 °C in SP4
medium [33] supplemented with 50 μg/mL cefoxitin
sodium salt (Sigma-Aldrich, Buchs, Switzerland) for 24 h
in broth medium or for 4 to 5 days on agar plates unless
otherwise described. SP4 agar plates were incubated at
37 °C in a humified atmosphere. The M. bovis strain
JF4278 was selected for microscopy experiments and
inhibition assays because it is a field strain isolated from
the milk of one of the first cows showing severe mas-
titis and pneumonia in Switzerland in 2008. The facul-
tative intracellular bacterium Listeria monocytogenes,
strain JF3263 [34], was used as a control for intracellu-
lar growth and was grown on Trypticase Soy Agar supple-
mented with 5% sheep blood (TSA 5% SB, Becton
Dickinson, Allschwil, Switzerland) at 37 °C.
Primary Embryonic Calf Turbinate (PECT) cells were
prepared from bovine fetuses. Briefly, cells were collectedTable 1 Strains of M. bovis used in this study
Isolate Origin Year of isolation Reference
Country Source
119B96 UK Lung 1996 [62]
JF4278 Switzerland Milk 2008 [63]
JF5261 Germany Milk 2012 This study
L63/93 Switzerland Lung 1993 This study
01-51020 Canada Lung 2001 [64]
01-48015 Canada Lung 2001 [64]from 3–5 months old fetuses (crown-rump-length: 25–
40 cm). Noses were shortly burned, cut and folded
back in order to expose the epithelium. The latter was
removed with a sterile curette and cut into small pieces.
Subsequently, 0.25% trypsin (1:250) (Biochrom, Berlin,
Germany) digestion for 30 min at room temperature with
stirring was carried out. Cells were grown and maintained
in minimal essential medium (MEM)-Earle medium sup-
plemented with 2.2 g/L NaHCO3 (Biochrom, Berlin,
Germany) and with 7% fetal calf serum at 37 °C in a
5% CO2 atmosphere as previously described [35,36]. The
quality of the cells was evaluated by light microscopy and
by TEM for characteristic morphological features. Cells
were routinely screened to ensure an absence of contam-
ination by mycoplasmas using PCR with the Venor®GeM
kit (Minerva Biolabs, Berlin, Germany) and by bovine
viral diarrhea virus using immunostaining with an in-
house swine anti-BVDV hyperimmune serum kindly pro-
vided by the National Reference Center for BVDV (Insti-
tute of Veterinary Virology, Vetsuisse Faculty, University
of Bern, Switzerland). Cell passages 5 to 8 only were used
for the experiments. Bovine cells were routinely seeded
24 h before experiments: 0.8 × 106 cells per 96-well plates
(~8.33 × 103 cells/well) (greiner bio-one, Frickenhausen,
Germany), 1.5 × 106 cells per 24-well plates (~6.25 × 104
cells/well) (TPP®, Techno Plastic Products AG, Klettgau,
Germany) and 1.5 × 106 cells per 6-well plates (~2.5 × 105
cells/well) (TPP®). Twenty-four hours later when the cells
were used, there were approximately: 2 × 104 cells/well in
96-well plates (for fluorescence microscopy assays), 7 ×
104 cells/well in 24-well plates (for gentamicin and cell
entry inhibition assays) and 3 × 105 cells/well in 6-well
plates (for TEM assays).
Turbinate cells infection model and gentamicin
protection assay
In order to standardize the in vitro infection model of
M. bovis using PECT cells, mycoplasma standard curves
of concentrations comparing OD600 values and 10-fold
serial dilutions were performed. Moreover, growth char-
acteristics of M. bovis were tested to assess variations
among each individual SP4 batch. For all in vitro experi-
ments, mycoplasma cultures were diluted in growth
medium to reach the required concentration taking
an OD600 of 0.1 corresponding to approximately 10
8
colony-forming units (CFU)/mL. Concentrations were
subsequently confirmed by plating 10-fold serial dilu-
tions for CFU enumeration.
M. bovis strain JF4278 was selected to study the sur-
vival of this bacterium in MEM-Earle medium and in
MEM-Earle preincubated with PECT cells either for 24
or 48 h, to confirm the inability of M. bovis to grow and
survive in MEM-Earle medium and in spent MEM-Earle
medium.
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more sensitive to detergents, the efficiency of mechan-
ical lysis of PECT cells was assessed. After growth to
confluence, PECT cells were scraped off the growth
plates and lysed by pipetting them up and down for a
few minutes using tips for 20–200 μL pipettes. Cell via-
bility and morphology were assessed by trypan blue
exclusion and by subsequent culture of the lysed PECT
cells. Since only 24-well plates were used for mycoplas-
mas enumeration after cell infection, bovine cells were
grown for 24 h in 24-well plates with the same condi-
tions as described above. They were further washed in
phosphate-buffered saline (PBS) at pH 7.5 and sus-
pended in 0.5 mL fresh MEM-Earle medium, scraped,
lysed and incubated for 10 days at 37 °C with 5% CO2.
For the infection assays, SP4 broth cultures of M. bovis
(Table 1) containing 105 CFU/mL were centrifuged
15 min at 8000 rpm and washed once in PBS at pH 7.5
and mycoplasmas were further suspended in MEM-Earle
medium in the same initial volume. PECT cells were
infected at a multiplicity of infection (MOI) between 2
and 30. Thereafter, a centrifugation step of 600 × g for
5 min was performed. Infected cells were washed at time
points 3 and 6 (hours) post infection to carry out the
same conditions as for the gentamicin protection assay
(see below). After several time points (h): 0, 6, and 54,
10-fold serial dilutions were spotted on SP4 agar plates
and incubated. Subsequently, colonies were counted
under a stereomicroscope. The assay was performed in
triplicates in two independent experiments.
Before starting the gentamicin protection assays, the
incubation time with gentamicin necessary to kill all
extracellular M. bovis at the concentration used for the
gentamicin protection assay was evaluated. A concentra-
tion of 400 μg/mL gentamicin sulfate (Sigma-Aldrich)
was chosen as used in previous studies [17,31]. The
bacteria were grown in SP4 broth at the concentration
used for infection assays as described above, pelleted by
centrifugation, suspended in MEM-Earle medium with
addition of a final concentration of 400 μg/mL gentamicin.
Ten-fold serial dilutions were spotted on SP4 agar plates at
0, 1 and 3 h to measure the survival time of M. bovis. The
plates were incubated and CFU/mL were determined.
For the gentamicin protection assay, M. bovis strains
(Table 1) were grown in SP4 broth until mid-log phase,
washed once in PBS and then suspended in MEM-Earle
medium to further infect PECT cells in a 24-well plate at
an MOI between 2 and 30. Thereafter, the plate was
centrifuged 5 min at 600 × g and then incubated for 3 h to
allow mycoplasmas to infect bovine cells. Cells were
washed twice with PBS and suspended in fresh MEM-
Earle medium supplemented with 400 μg/mL gentamicin
sulfate. The plate was incubated for 3 h (total of 6 h post
infection). Thereafter wells were washed three times withPBS, and fresh MEM-Earle medium without gentamicin
was added to each well. At different time points (h), 0, 6
and 54 post infection, wells were washed once with PBS
and bovine cells were scraped off the growth plates and
further mechanically lysed as described above. Samples
were taken to measure the quantity of mycoplasmas inside
the cells to determine the CFU/well. As controls, assays
were performed for all strains without addition of the anti-
biotic, as well as with PECT cells and mycoplasmas alone.
Moreover, to measure the kinetic of the growth of M.
bovis during the gentamicin protection assay, a growth
curve was determined for strain JF4278 as described above
for the gentamicin protection assay but including the
following time points (h): 0, 3, 6, 30, 54, 78 and 102 post
infection. All assays were performed in triplicates in two
independent experiments.
During the experiment, cells were visualized by light
microscopy. At each time point, cells were fixed with
methanol and stained with crystal violet solution (0.75 g
crystal violet, 0.25 g NaCl, 1.75 mL formaldehyde in a
final volume of 100 mL of 50% ethanol:ddH2O).
Inhibition of endocytic pathways in PECT cells
To investigate the mechanism of entry of M. bovis into
PECT cells, endocytosis dependent on clathrin-coated
vesicles, lipid rafts/caveolin mediated endocytosis and
macropinocytosis were individually blocked with several
chemical inhibitors (summary in Additional file 1). For-
mation of clathrin-coated vesicles was inhibited with
monodansylcadaverine (MDC) (Sigma-Aldrich), which
blocks the assembly of clathrin-coated pits at the plasma
membrane, with chlorpromazine (CPZ) (Sigma-Aldrich),
a clathrin sequestering agent preventing clathrin recyc-
ling in endosomes [37] and with hypertonic sucrose,
which removes clathrin lattices from the plasma mem-
brane [38]. Lipid rafts/caveolin based endocytosis oc-
curs in cholesterol rich regions of the cellular plasma
membrane [39] and was blocked using methyl-ß-cyclo-
dextrin (MßCD) (Sigma-Aldrich), a substance removing
cholesterol from the cell membranes and thereby dis-
turbing the lipid structure [40], nystatin (Sigma-Aldrich),
which sequesters cholesterol [37] and simvastatin (Merck
Millipore, Darmstadt, Germany), a statin inhibiting the
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)
reductase, a rate-limiting enzyme of cholesterol biosyn-
thesis [41]. Macropinocytosis was prevented by treatment
with amiloride hydrochloride (Merck Millipore) and 5-
(N-Ethyl-N-Isopropyl)-amiloride (EIPA) (Enzo Life Sci-
ences, Lausen, Switzerland), which both block Na+/H+
exchange and thereby decrease the submembranous
intracellular pH. This leads to disturbance of actin re-
modeling necessary for efficient macropinocytosis [42].
Moreover, cytochalasin D (Sigma-Aldrich), which blocks
actin polymerization was tested [43]. Since modulation of
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chalasin D) and caveolae-mediated endocytosis (cyto-
chalasin D) [44], those chemicals are not considered as
specific inhibitors of macropinocytosis. For this reason,
two additional inhibitors of the phosphoinositide-3 kin-
ase (PI3K), namely wortmannin (Merck Millipore) and
LY-294002 (Merck Millipore) were used. These chemicals
inhibit macropinocytosis and phagocytosis [45], although
it has to be mentioned that they were previously described
as possibly interfering with clathrin- and caveolin-
mediated endocytosis [46], therefore showing a pleiotropic
effect as well.
In a previous study, FACS analysis showed only weak
cytotoxicity of inhibitors as 0.2 mM MDC, 25 μM CPZ,
12.5 μg/mL nystatin, 10 mM MßCD and 20 μM EIPA
towards PECT cells [47]. To study possible cytotoxic
effects of amiloride hydrochloride, simvastatin, sucrose,
cytochalasin D, wortmannin and LY-294002 towards
PECT cells, chemicals were added to cells at the concen-
trations defined below, incubated either 3.5 h, or 27 h
for simvastatin, at 37 °C supplemented with 5% CO2,
thereafter stained with crystal violet solution and viewed
under the stereomicroscope.
Additionally, the effect of each inhibitor on growth of
M. bovis strain JF4278 was evaluated. MEM-Earle
medium was mixed individually with 25 μM CPZ,
0.2 mM MDC, 10 mM MßCD, 12.5 μg/mL nystatin,
10 μM simvastatin, 5 mM amiloride hydrochloride,
20 μM EIPA, 100 nM wortmannin, 20 μM LY-294002,
0.45 M sucrose, or 5 μg/mL cytochalasin D as previously
described [20,37,47-50] and incubated with M. bovis
strain JF4278 for 3 h at 37 °C supplemented with 5%
CO2.
To test the blocking of uptake of M. bovis, PECT cells
were grown in a 24-well plate to reach confluence and
incubated 24 h prior to infection with simvastatin or
30 min prior to infection for all other inhibitors with the
specific concentration described above. M. bovis strain
JF4278 was grown in SP4 medium and diluted to 105
mycoplasmas per well to infect pretreated PECT cells
(no removal of inhibitors) at an MOI between 2 and 30
as used for the gentamicin protection assay. Further
steps were performed as described above for the genta-
micin protection assay. Cells were mechanically lysed
and samples taken at 0 and 10 h after infection. This last
time point was chosen to avoid measuring interferences
of the inhibitors with intracellular growth as it was pre-
viously determined that at this time point after infection,
M. bovis is at the beginning of the logarithmic growth
phase (Figure 1). Ten-fold dilutions were spotted on SP4
agar and M. bovis colonies were counted. Negative con-
trols consisted of the infection of untreated eukaryotic
cells. Assays were performed in triplicates in two inde-
pendent experiments.Fluorescence microscopy with differential staining
Fluorescence microscopy was performed to distinguish
between intra- and extracellular mycoplasmas during
cell infection using an antibody independent differen-
tial staining [51]. The principle is to label bacteria with
5/6-carboxylfluorescein-succinimidyl ester (NHS-Fluor-
escein), a molecule derived from fluorescein, which is
membrane impermeable and specifically binds to primary
amines (lysine side chains) of membrane proteins. Subse-
quently, bacteria were biotinylated. After infection of
eukaryotic cells with labeled and biotinylated bacteria,
cells were fixed and extracellular bacteria are stained with
streptavidin. This method allows differential staining of
intracellular and extracellular bacteria without requiring
any antibodies and cell permeabilization.
More specifically, M. bovis strain JF4278 was grown
until mid-log phase. As negative control and to assess a
possible passive internalization of particles into PECT
cells, mycoplasma cultures were divided in 2 parts and
one part was inactivated by treatment with 3% formal-
dehyde for 30 min. Mycoplasmal viability was evaluated
by culture of 10-fold serial dilutions on SP4 agar plates.
L. monocytogenes strain JF3263 was used as a positive
control for facultative intracellular bacteria and was
grown overnight. The next day, several colonies were
picked from the plate and transferred into 1 mL MEM-
Earle Medium for further processing. Inhibition of L.
monocytogenes bovine cell invasion was also tested by
treatment with 3% formaldehyde for 30 min. Inactiva-
tion of L. monocytogenes was assessed by plating 10-
fold serial dilutions on blood agar plates. Bacterial
strains were then washed twice with PBS at pH 7.5 and
suspended in 15 μg/mL 5/6-NHS-Fluorescein (Thermo
Fisher Scientific) solubilized in PBS. After an incuba-
tion period of 15 min at 4 °C on a shaker, succinimidyl-
6-(biotinamido) hexanoate (EZ-Link NHS-LC-biotin)
(Thermo Fisher Scientific) was added at a final concen-
tration of 0.3 mg/mL in PBS. EZ-link NHS-LC-biotin is
membrane permeable and binds to and biotinylates
intracellular and membrane primary amines of pro-
teins. The FITC-biotin mixture was then incubated for
30 min at 4 °C, washed three times with PBS and
suspended in PBS with 1% albumin.
PECT cells were seeded in 96-well μ-clear plates
(greiner bio-one), which minimize background fluores-
cence, and then infected with the biotinylated and NHS-
fluorescein-labeled bacteria at an MOI of 3400 for 6 h
for M. bovis. This higher MOI was used in order to de-
crease the time of infection because when mycoplasmas
multiply, stains are diluted and fluorescence is no more
clearly detectable. In the case of L. monocytogenes, an
MOI of 55 and infection for 3 h at 37 °C with 5% CO2
was performed since at higher MOIs L. monocytogenes
was cytotoxic to bovine cells. PECT cells alone were
Figure 1 Intracellular growth curve of M. bovis in PECT cells. Broken line and crosses: M. bovis strain JF4278 with gentamicin. Continuous line
and dots: PECT cells and M. bovis strain JF4278 with gentamicin. The data shown are the mean values of triplicates of 2 independent experiments
and standard deviations of individual measurements are indicated as bars. *P < 0.05, **P < 0.01.
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fixed for 20 min with 4% formaldehyde, washed three
times with PBS and blocked for 5 min with PBS comple-
mented with 10% calf serum.
Streptavidin Alexa Fluor® 647 Conjugate (Invitrogen,
Life Technologies, Carlsbad, USA) diluted 1:200 in blo-
cking buffer was added and the biotinylated myco-
plasmas were successively stained for 45 min at room
temperature. Streptavidin is a biotin binding protein,
membrane impermeable and therefore only stains extra-
cellular mycoplasmas. Wells were then washed three
times with PBS and cell nuclei were stained with a solu-
tion of 4′,6-diamidino-2-phenylindole (DAPI dilactate)
(Sigma-Aldrich) at a concentration of 1 μg/mL in PBS.
Thereafter, cells were stained for 15 min with rhodamine
phalloidin (Invitrogen), diluted 1:200 in PBS. Phalloidin
selectively binds to F-actin thus visualizing the whole
structure of eukaryotic cells. Wells were finally washed
three times with PBS and stored at 4 °C in the dark until
further processing. To confirm that bacterial staining
was correctly performed, M. bovis labeled with either
NHS-Fluorescein or Streptavidin Alexa 647 alone wereseeded in wells without PECT cells, fixed, washed and
stored at 4 °C in the dark until analysis.
Cells were visualized using the INCell Analyzer 2000 sys-
tem (General Electric Healthcare, Glattbrugg, Switzerland).
Four to 30 regions per well were selected and images ob-
tained using a wide field epifluorescence microscope with
a Nikon objective lens (60x/NA 0.70), at a working dis-
tance of 1.8 mm and using the filters for FITC (Excitation
filter at 490 nm, Emission filter at 525 nm) for the
visualization of the NHS Fluorescein stain, Cy5 (Ex.:
645 nm, Em.: 705 nm) for Streptavidin Alexa 647, DAPI
(Ex.: 350 nm Em.: 455 nm) for the DAPI stain and Cy3
(Ex.: 543 nm, Em.: 605 nm) to see the F-actin stained by
rhodamine phalloidin. Images were analyzed and merged
images were acquired using the INCell Investigator 1.6.2
software (GE Healthcare).
Fluorescence microscopy using antibodies directed
against M. bovis
To confirm the strict intracellular multiplication of
M. bovis, gentamicin treated infected cells (having the
same conditions than in the gentamicin protection assay
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well as untreated controls were fixed with 4% formalde-
hyde at time point 54 h. Subsequently, two different
conditions were used: permeabilized and not perme-
abilized PECT cells. Briefly, permeabilized cells were
treated for 20 min at room temperature with 0.2% triton
X-100 in blocking buffer (5% inactivated horse serum in
PBS). All cells were further washed three times with
PBS. Cells were stained by addition of a mouse mono-
clonal IgG1 antibody specific to M. bovis (Thermo Sci-
entific, Reinach, Switzerland) at a dilution of 1:100 for
90 min at room temperature. Thereafter cells were
washed and goat polyclonal anti-mouse secondary IgGs
(γ-chain specific) FITC-conjugated (Sigma Aldrich) at a
dilution of 1:100 were added for 90 min at room
temperature. After washing cells three times with PBS,
cell nuclei were stained with DAPI dilactate (Sigma Al-
drich) at a dilution of 1:2000 for 15 min followed by
staining F-actin using 100 nM rhodamin phalloidin
(Lubio Science GmbH, Lucerne, Switzerland) for 30 min
at room temperature. Then wells were washed and
stored at 4 °C in the dark until analysis with the INCell
Analyzer 2000 system (General Electric Healthcare) as
described above.Transmission electron microscopy
TEM was performed to visualize M. bovis during in vitro
cell infection. PECT cells were seeded in 6-well plates.
Thereafter, cells were infected with strain JF4278 as
described above at an MOI of 600 and incubated for
16 h. The negative control consisted of PECT cells alone.
After incubation, cells were first washed once with PBS
prewarmed to 37 °C and subsequently fixed with 1.5%
glutaraldehyde in 0.1 M cacodylate buffer pH 7.4 for
30 min at 37 °C. After three more washes in cacodylate
buffer, bacteria were post-fixed with 1% OsO4 (Chemie
Brunschwig, Basel, Switzerland) in 0.1 M cacodylate
buffer for one hour at 4 °C and again washed three times
with cacodylate buffer. Thereafter, cells were dehydrated
in an ascending ethanol series and embedded in Epon, a
mixture of Epoxy embedding resin, dodecenyl succinic
anhydride (DDSA) and methyl nadic anhydride (MNA)
(Sigma Aldrich). Epon was polymerized for 5 days at
60 °C. Resin blocks were then trimmed and ultrathin
sections of 60 nm were obtained with diamond knives
(Diatome, Biel, Switzerland) on a Reichert-Jung Ultracut
E (Leica, Heerbrugg, Switzerland). Sections were double-
stained with 0.5% uranyl acetate for 30 min at 40 °C
(Sigma Aldrich, Steinheim, Germany) and 3% lead
citrate for 10 min at 20 °C (Laurylab, Saint Fons, France)
in an Ultrastain® (Leica, Vienna, Austria) and examined
with a Philips CM12 transmission electron microscope
(FEI, Eindhoven, The Netherlands) at magnificationsranging from 4400 × to 15 000 ×. Micrographs were cap-
tured with a Mega View III camera using the iTEM soft-
ware (version 5.2; Olympus Soft Imaging Solutions
GmbH, Münster, Germany).Statistical analysis
M. bovis titers (log10 [CFU/well]) measured during in-
fection assays are shown as means ± standard deviations
of triplicate values from two independent experiments.
For the inhibition of endocytosis assay, all values were
normalized to untreated control samples. The signifi-
cance of differences between individual groups in the as-
says was calculated with the Student’s t-test. Differences
among individual strains in the same group were calcu-
lated using the Kruskal-Wallis nonparametric ANOVA
test and in case of a p-value of <0.05, post hoc tests were
done using Dunn’s multiple comparison test using the
software GraphPad Instat™ V2.05 (GraphPad Software
Inc., La Jolla, CA, USA).Results
PECT model for M. bovis infection
Since primary cells were used, we attempted to cha-
racterize the type of cells present more in detail. Morpho-
logical features of PECT cells were checked by light
microscopy and by TEM. Until passage number 8 the ma-
jority of the cells were polygonal (epithelial-like), while at
passage number 10 most of the cells were fusiform (fibro-
blast-like) (Figure 2). Moreover in transmission electron
micrographs, cells displayed scarce microvilli all along the
plasma membrane and didn’t show any sign of polar dif-
ferentiation. We found no evidence of cilia or of mucous
granules. Furthermore, cell population looked morpho-
logically uniform.
None of the M. bovis strains used in this study grew in
the medium used for eukaryotic cell culture as bacterial
concentrations decreased after 6 h incubation in MEM-
Earle (Figure 3) and in spent MEM-Earle for strain JF4278
(Additional file 2). Most of the M. bovis strains tested lost
viability after 54 h incubation in MEM-Earle. Mycoplasma
concentrations remained stable in co-culture with PECT
cells (MOI between 2 and 30), when cells were not treated
with gentamicin, with a slight increase 54 h post infection
(Figure 3).
In order to lyse bovine cells without damaging myco-
plasmas, mechanical lysis of PECT cells was evaluated.
Trypan blue exclusion of lysed PECT cells did not show
any viable cells. Subsequent seeding of lysed cells led to
less than 10 cell islands per well after 4 days incubation
indicating the survival of only very few PECT cells after
mechanical lysis and corroborating the effectiveness of
this method for further experiments to evaluate the
intracellularity of M. bovis in eukaryotic cells.
Figure 2 PECT cells morphology by light microscopy. Morphological features of PECT cells stained with crystal violet. Panel A: PECT cells at
passage 8. Panel B: PECT cells at passage 10. Magnification 112.5 ×.
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Infection of PECT cells with M. bovis at 105 CFU/0.5 mL,
corresponding to an MOI between 2 and 30 and incu-
bated in MEM-Earle medium supplemented with 400 μg/
mL gentamicin sulfate, resulted in the death of all M.
bovis cells after 3 h (Figure 4). After 3 h incubation withFigure 3 Infection model of M. bovis with PECT cells. Time points 0, 6 a
Horizontally striped columns correspond to M. bovis alone in growth medi
The data shown are the mean values of triplicates of 2 independent exper
as bars. *P < 0.05, **P < 0.01, ***P < 0.001.gentamicin (6 h post infection), mycoplasma titers in in-
fected PECT cells decreased 103 times (Figure 4). At 48 h
post treatment with gentamicin (54 h post infection),
values increased to between 104 CFU/well and 106 CFU/
well (Figure 4). The intracellular growth curve of strain
JF4278 showed that after the logarithmic growth of
approximately 104 mycoplasmas, a plateau was reachednd 54 h post infection with an MOI between 2 and 30 are shown.
um, while filled columns correspond to the infection of PECT cells.
iments. Standard deviations of individual measurements are indicated
Figure 4 Gentamicin protection assay. Time points 0, 6 and 54 h post infection with an MOI between 2 and 30 are shown. Time 6 h post
infection corresponds to the end of the gentamicin treatment. Diagonally striped columns correspond to M. bovis alone in growth medium
supplemented with gentamicin, while dotted columns correspond to the infection of PECT cells with growth medium supplemented with
gentamicin. The data shown are the mean values of triplicates of 2 independent experiments. Standard deviations of individual measurements
are indicated as bars. *P < 0.05, **P < 0.01, ***P < 0.001.
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cells were observed by light microscopy, and were shown
to remain attached to the plate. In the controls, myco-
plasmas alone without eukaryotic cells immediately died
after the gentamicin treatment (Figures 1 and 4).
M. bovis may enter PECT cells via a non-classical endocytic
pathway
Preliminary tests to evaluate the effect of chemical inhibi-
tors towards growth of M. bovis and cytotoxicity towards
PECT cells were performed. Growth of mycoplasmas was
totally inhibited or decreased by 10 mM MßCD and
5 mM amiloride hydrochloride, but not by 25 μM CPZ,
12.5 μg/mL nystatin, 0.2 mM MDC, 10 μM simvastatin,
20 μM LY-294002, 0.45 M hypertonic sucrose, 5 μg/mL
cytochalasin D, 100 nM wortmannin, and 20 μM EIPA
(Additional file 1). Consequently MßCD and amiloride
hydrochloride were excluded from further experi-
ments. Moreover, incubation of PECT cells with 10 μM
simvastatin and 20 μM LY-294002 for 3 h showed no
cytotoxic activity, whereas, incubation with 0.45 M sucrose,5 μg/mL cytochalasin D, 5 mM amiloride hydrochloride
and 100 nM wortmannin were associated with PECT cell
death after 3 h incubation (Additional file 1). Therefore
these four chemicals were excluded from the experiment.
PECT cells pretreated with drugs to block bacterial cell
entry in eukaryotic cells showed no clear inhibition of
M. bovis invasion 10 h post infection (Figure 5). How-
ever, it has to be noted that results obtained after
cell treatment with MDC and CPZ, both inhibitors of
clathrin-mediated endocytosis revealed inhibition in cer-
tain assays, but showed variability between individual
assays (Figure 5).
Extra- and intracellular M. bovis visualization by
fluorescence microscopy
Differential staining was performed to distinguish between
intracellular and extracellular M. bovis by fluorescence
microscopy. Intracellular M. bovis were only stained by
NHS-Fluorescein and visualized in green, while extracellu-
lar mycoplasmas were stained with NHS-Fluorescein and
Streptavidin-Alexa 647 and appeared in yellow-orange
Figure 5 Inhibition of M. bovis entry in PECT cells by chemical treatment. The data shown are the mean values of the triplicates of 2
independent experiments at time 0 and 10 h using an MOI between 2 and 30, the latter 4 h after the gentamicin incubation time. Standard
deviations of the individual measurements are indicated as bars. *P < 0.05.
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(blue) and F-Actin was visualized with rhodamine phal-
loidin (red) (Figure 6, panels A, B and C). Many
extracellular M. bovis clusters were visible surrounding or
attaching to the PECT cells since no gentamicin was added
in this experiment (Figure 6, panel B). Intracellular
mycoplasmas were visible as clusters within PECT cells but
did not show any clear localization in a specific cell
compartment (Figure 6, panel B). In the control, using
formaldehyde-inactivated mycoplasmas, adhesion and inva-
sion were almost totally inhibited (Figure 6, panel C).
L. monocytogenes used as positive control confirmed
the efficacy of this method to distinguish between intra-
cellular and extracellular bacteria (Figure 6, panel E). In
this case only one L. monocytogenes per eukaryotic cell
was observed (Figure 6, panel E) but using a low MOI
because of the cytotoxicity observed towards PECT cells.
Moreover, using formaldehyde-inactivated listerias, ad-
hesion and invasion were inhibited (Figure 6, panel F).Moreover, fluorescence microscopy using mouse mono-
clonal antibodies directed against M. bovis was used to
assess intracellular replication. When infection was per-
formed without treatment with gentamicin and cells were
stained after cell permeabilization, intracellular and extra-
cellular M. bovis were visible (Figure 7, panel A), while
when cells were not permeabilized only extracellular
mycoplasmas were detected (Figure 7, panel B). More-
over, when infection was followed by treatment with gen-
tamicin, M. bovis could be observed intracellularly when
cells were permeabilized (Figure 7, panel C) but not if
cells were stained without a previous step of permea-
bilization (Figure 7, panel D).Ultrastructural characterization of internalization of
M. bovis
In the micrographs, PECT cells displayed scarce microvilli
all along the plasma membrane and didn’t show any sign
Figure 6 Differential fluorescence microscopy of PECT cells infection with M. bovis and L. monocytogenes. Panels A, B and C: infection
with M. bovis at an MOI of 3400, 6 h post infection. Panels D, E and F: infection with L. monocytogenes at an MOI of 55, 3 h post infection. Panels
A and D: negative controls. Panels B and E: infected cells. Panels C and F: cells infected with formaldehyde-inactivated bacteria. Nuclei are stained
in blue, F-actin is stained in red, intracellular bacteria are stained in green and extracellular bacteria are stained in yellow-orange. Merged images.
Magnification 600 ×.
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of mucous granules. Thus, as the cells were lacking such
specific features, morphology was closest to basal or prin-
cipal cells. Moreover, cell population looked uniform.
In TEM experiments, M. bovis cells appeared as
pleomorphic but mostly oval to elongated structures of
0.8 μm to 2 μm length and 0.1 μm to 0.3 μm in width,
showing varying electron densities (Figure 8, panels A
and B). At 16 h post infection, bacteria were mostly
found in close proximity or adhering to the cells. Intra-
cellular M. bovis were observed in vesicle-like structures
having a second membrane layer, the plasmalemma of
the mycoplasmas being occasionally separated from the
vesicle’s membrane by an electron-lucent space (Figure 8,
panel B). Moreover, several mycoplasmas were seen
with electron-lucent spaces in their cytoplasm (Figure 8,
panel C). Multiple invaginations at the cell surface,
50 nm-100 nm in diameter with openings of approxi-
mately 50 nm and various submembranous vesicles of50–100 nm in diameter were seen in PECT cells where
mycoplasmas adhered to bovine cells (Figure 8, panel B).
Discussion
The present study demonstrates the ability of M. bovis
to invade, persist and multiply in PECT cells. These cells
were chosen instead of characterized cell lines in order
to observe mechanisms that are the closest to the
in vivo situation. Possible cell types from the respiratory
epithelium include basal cells, principal cells, ciliated
cells and goblet cells. Moreover, a minimal contamin-
ation with fibroblasts from the lamina propria cannot be
totally excluded. As primary cells contain mixed cell
types, cells were checked for morphological features by
light microscopy and by TEM. Until passage number 8,
the majority of the cells were polygonal (epithelial-like),
while at passage number 10 most of the cells were
fusiform (fibroblast-like) (Figure 2). For this reason, only
cells at passage numbers between 5 and 8 were used for
Figure 7 Fluorescence microscopy of the gentamicin protection assay with permeabilized and not permeabilized cells using
antibodies directed against M. bovis. MOI of 10; 54 hours post infection. Panel A: Permeabilized PECT cells without gentamicin treatment
infected with M. bovis JF4278. Mycoplasmas are visible intra- and extracellularly. Panel B: Non permeabilized PECT cells without gentamicin
treatment infected with M. bovis JF4278. Only extracellular mycoplasmas are visible. Panel C: Permeabilized PECT cells with gentamicin treatment
infected with M. bovis JF4278. Only intracellular mycoplasmas are visible. Panel D: Not permeabilized PECT cells with gentamicin treatment
infected with M. bovis JF4278. No mycoplasmas are visible. Nuclei are stained in blue, F-actin is stained in red, mycoplasmas are stained in green.
Merged images. Magnification 600 ×.
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cell morphology was closest to basal or principal cells
and was fairly uniform. At low MOI, between 2 and 30,
all M. bovis strains survived within PECT cells and were
able to multiply, reaching 103 until 104 times the initial
CFU values 48 h after removal of gentamicin. ThisFigure 8 Transmission electron microscopy of PECT cells infected with M
cell, M. bovis clusters (bold arrow). Panel B: PECT cell invagination (thin arro
M. bovis (bold arrow). Panel C: electron-lucent space in mycoplasmal cytopcorresponds to an average generation time of at least
5.7 h, which is about twice the generation time under
axenic growth conditions. These results suggest that M.
bovis multiplies inside PECT cells since M. bovis is not
able to survive or multiply in MEM-Earle or in spent
MEM-Earle media. Gentamicin was previously shown to. bovis. MOI of 600, 16 h post infection. Panel A: M. bovis infected PECT
w), intracellular vesicles (arrowhead), intracellular, membrane-bound
lasm (thin arrow). N: PECT cell nucleus; C: PECT cell cytoplasm.
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[52] but some leakage of this antimicrobial substance in-
side PECT cells cannot be excluded especially at the high
concentration of 400 μg/mL used for the gentamicin
protection assay. For this reason, treatment was limited
to 3 h and after killing of all extracellular mycoplasmas,
gentamicin was not added anymore. Interestingly, M.
bovis showed no apparent cytotoxicity towards PECT
cells and the latter even continued to multiply during
long infection periods of 78 h.
The ability of M. bovis to invade and persist in PECT
cells raised the question of the mechanism used to enter
epithelial cells. The approach chosen was to block differ-
ent mechanisms of bacterial cell entry by pretreatment
with specific inhibiting drugs. None of the chemicals
tested under the conditions used in this infection model
showed a clear inhibition of M. bovis entry in PECT
cells. However, MDC and CPZ demonstrated a high
variability of inhibition of entry of M. bovis in PECT
cells, although with variable effects in between experi-
ments, blocking almost 80% of mycoplasmal cell entry in
an individual experiment. Endocytosis comprises com-
plex mechanisms leading to membranes modifications
and cytoskeleton rearrangements [53] but our findings
suggest that M. bovis may invade PECT cells via another
endocytic pathway than those tested. However, we can-
not exclude that clathrin-mediated endocytosis is not
also involved. This hypothesis could explain the incon-
sistent blocking of entry with MDC and CPZ through
the switching to another mechanism of M. bovis entry in
PECT cells. MDC and CPZ are known to indirectly im-
pact actin dynamics; MDC via inhibition of transgluta-
minases and CPZ through inhibition of phospholipase C
[54]. These chemicals may also potentially interfere to a
various extent with an alternative mechanism of cell
entry requiring actin assembly and dynamics. Another
explanation is that this cell model is based on primary
cells. It cannot be excluded that a variation in the pro-
portion of the type of cells present between the two
experiments influenced the results. Previous studies in
other Mycoplasma sp. suggested a role of cytoskeleton
rearrangements [20,55,56] and recently, Fürnkranz et al.
observed a slight decrease in cell invasion after choles-
terol depletion of HeLa cell membranes [54]. In contrast,
we didn’t observe any inhibition of cell entry by blocking
lipid rafts/caveolin based endocytosis, and results were
consistent concerning nystatin.
The differential staining method used for fluorescence
microscopy [51] was advantageous since no specific anti-
bodies were required to visualize extra- and intracellu-
larly located M. bovis. However, high MOIs should be
used for this experiment because bacterial replication
dilutes the dyes resulting in less detectable fluorescence.
This method was previously shown to not interfere withinvasiveness of Neisseria gonorrhoeae and Staphylococcus
aureus [51]. It has to be mentioned that even at high
MOIs, M. bovis was not detected inside each individ-
ual bovine turbinate cell. However numerous clusters
of mycoplasmas adhering to the plasma membrane of
PECT cells were seen. Intracellularly, M. bovis appeared
in clusters with no apparent localization in specific cellu-
lar compartments as it was observed for M. gallisepticum
in HeLa-229 cells and chicken embryo fibroblasts (CEF)
by double immunofluorescence microscopy [20] or M.
pneumoniae in normal human bronchial epithelial cells
by immunofluorescence microscopy [57]. M. synoviae is
spread throughout the cytoplasm but is also observed in
clusters around the nuclei in the human epithelial cell line
HEp-2 as investigated by confocal laser scanning micros-
copy [58] and M. genitalium strains G37 and 1019 V are
found peri-, and intranuclearly in HeLa and EM42 cells
using immunofluorescence and confocal microscopy [59].
M. bovis strain Mb1, invading different populations of
PBMCs, displayed different intracellular patterns depend-
ing on the individual cell population or the time of
infection [31]. Moreover, fluorescent staining of M. bovis
without prior permeabilization of turbinate cells con-
firmed the intracellular replication of mycoplasmas. Inter-
estingly, formaldehyde-inactivated M. bovis did not
invade PECT cells, and no adherence to bovine cells was
observed but for residual spots probably due to the high
concentration of M. bovis used in this experiment. The
control using formaldehyde-inactivated L. monocytogenes
did not show specific spots. However, this variation can
be due to the very low MOI used for L. monocytogenes
because of its high cytotoxicity toward PECT cells. Adhe-
sion is necessary for further cell invasion but the fact that
inactivated M. bovis are not able to invade PECT cells
would suggest the involvement of an active mechanism.
Morphologically, TEM experiments revealed M. bovis
as oval to elongated electron dense structures of 0.8 μm
to 2 μm length and 0.2 μm to 0.3 μm width in agree-
ment with previous descriptions from Maeda et al. [32].
Kleinschmidt et al. [22] reported M. bovis to be round to
oval or pleomorphic with a diameter of 0.45-0.80 μm
and sometimes found the microorganisms within the
cytoplasm of phagocytes, in phagosomes and/or phago-
lysosomes but not in bronchial epithelial cells by TEM
of lung tissue sections. This raises the question of differ-
ent M. bovis-cell interactions dependent on host cells. In
the present study, multiple mycoplasmas were seen with
electron lucent spaces in their cytoplasm, varying in size,
as already described by Hirth et al. [60]. However, the
lucent spaces were rather small, approximately 150 nm
in diameter and poorly defined. Sub-membrane vesicles
of 50–100 nm in diameter were observed in PECT cells.
The intracellular behavior of some other Mycoplasma
species was already studied more intensively by TEM
Bürki et al. Veterinary Research  (2015) 46:53 Page 13 of 14and some comparisons among differences or similarities
among Mycoplasma species can be highlighted. M. suis
strain 08/07 has been observed inside porcine RBCs in
intraerythrocytic vacuoles or free in the cytoplasm [16].
These features were also observed by Vancini and
Benchimol, who investigated the ultrastructural charac-
teristics of M. hominis strain ATCC 23114 in Trichomo-
nas vaginalis and found them inside vacuoles, in close
proximity to, or even fused with vacuolar membranes, or
free inside the cytosol [18]. In contrast, intracellular
M. genitalium strains G37 and M2300 were seen in vacu-
oles throughout the cytosol but mainly in a perinuclear lo-
cation [61]. Extracellular M. genitalium was also observed
attached to the plasma membrane of vaginal epithelial
cells. In those attachment regions, the mycoplasmas de-
velop polarized electron-dense core structures similar to
the electron-dense core seen in terminal tip structures of
M. genitalium [61].
In summary, M. bovis is able to invade, persist and
multiply in PECT cells. The intracellular survival of
M. bovis could represent a protective niche for this
bacterium to escape both the host’s immune defense as
well as therapy of affected animals with antibiotics.
Moreover, the intracellular survival of M. bovis can lead
to healthy carrier animals and thus to a more wide-
spread transmission of the pathogen within cattle herds.Additional files
Additional file 1: Inhibitors used to block the different endocytosis
pathways. Table summarizing the inhibitor drugs used to block M. bovis
entry in PECT cells.
Additional file 2: Growth curve of strain JF4278 in fresh and spent
MEM-Earle medium. Growth curve showing the survival of M. bovis in
fresh and spent medium used for eukaryotic cell culture.
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